Playback speed
10 seconds
ASCO 2021 OlympiA Trial Update on BRCA1/2 High-Risk HER2- EBC: Adjuvant Olaparib After (Neo)adjuvant Chemotherapy
304 views
August 3, 2021
Login to view comments.
Click here to Login